Google
OSTX — OS THERAPIES INCORPORATED (Healthcare >> Biotechnology)
OSTX FAQ
What is OSTX's ROE?
OS THERAPIES INCORPORATED reports a Return on Equity (ROE) of 361.65%.
What is OSTX's dividend yield?
OS THERAPIES INCORPORATED offers a dividend yield of 0.00%.
What is OSTX's Deepscope Quality Score?
Deepscope rates OSTX's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy OSTX?
Deepscope's AI Timing Score for OSTX is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does OSTX belong to?
OS THERAPIES INCORPORATED is classified under the Healthcare >> Biotechnology sector on the NYSE MKT exchange.
|
USD 1.78
Price
-0.07
(-3.78%)
Day Change
|
|
|---|
OSTX, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROEが昨年度比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.78 |
| PBV / Sector |
-7.41 / 4.63
|
| Earning Per Share | -0.78 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
1.54 M
GREAT
|
| Average 1W Daily Value |
1.86 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:08:51 |
| Symbol | OSTX |
| Name | OS THERAPIES INCORPORATED |
| Sector | Healthcare >> Biotechnology |
| Market | NYSE MKT |
| Listed Shares | 44.54 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 80.17 / 8,857.28 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 115 Pullman Crossing Road, Grasonville, MD, United States, 21638
Phone: 410 297 7793
Website: https://ostherapies.com
Sector: Healthcare >> Biotechnology
Description: OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
